Doxorubicin, Free Base **
如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: Doxorubicin, Free Base **
產(chǎn)品型號(hào): LC D-4099
產(chǎn)品展商: 原裝進(jìn)口
產(chǎn)品文檔: 無(wú)相關(guān)文檔
簡(jiǎn)單介紹
Doxorubicin, Free Base **
Doxorubicin, Free Base **
的詳細(xì)介紹
Doxorubicin, Free Base **
產(chǎn)品名稱：Doxorubicin, Free Base
產(chǎn)品貨號(hào)：LC D-4099
產(chǎn)品規(guī)格：100 MG
This is the free base form of doxorubicin; please see our product Doxorubicin, Hydrochloride Salt, Cat. No. D-4000, for further technical information. The hydrochloride salt form of doxorubicin, not the free base, is used in the doxorubicin formulation for use in humans.
Doxorubicin is the active ingredient in the drug product sold under the trade name Adriamycin® and the other trade names listed above under "Related Terms". This drug has been approved in at least one country for use in patients with a wide range of cancers. NOTE: THE DOXORUBICIN, FREE BASE RESEARCH COMPOUND SOLD BY LC LABORATORIES IS NOT ADRIAMYCIN® NOR ANY OTHER DRUG PRODUCT SPECIFIED BY THE TRADE NAMES LISTED ABOVE UNDER "RELATED TERMS", AND IS NOT FOR HUMAN USE.
NOTE: the trade names listed above under "Related Terms" are for doxorubicin-containing drug products and they may apply variously to one or another form of doxorubicin, such as the free base, hydrochloride salt or other salt form.
This doxorubicin product is the free base, whose CAS number is given above. The CAS number of the hydrochloride salt is 25316-40-9.
Several CAS numbers previously assigned to doxorubicin free base, namely 23257-17-2, 24385-08-8, 25311-50-6 and 29042-30-6, have been deleted by CAS and are no longer in use.
Sold for laboratory or manufacturing purposes only; not for human, medical, veterinary, food, or household use.
This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
Not available in some countries; not available to some institutions; not available for some uses.
Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO. Disposal: A
